SCHEMBL2103149

SCHEMBL2103149

[CH2]S(=O)(=O)N1CCN(c2ccc(F)cc2)CC1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.65
MAPT P10636 3/20 0.58
HPGD P15428 1/20 0.57
LMNA P02545 3/20 0.54
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
POLB P06746 3/20 0.54
TDP1 Q9NUW8 2/20 0.54
HSD11B1 P28845 1/20 0.54
MAPK1 P28482 2/20 0.53
HTT P42858 2/20 0.53
GFER P55789 1/20 0.53
TSHR P16473 1/20 0.51
USP30 Q70CQ3 1/20 0.50
PKM P14618 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
CA12 O43570 1/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CA9 Q16790 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31605436 0.83 ALDH1A1 (0.67) ALDH1A1MAPTHPGDLMNAMEN1
SCHEMBL2968565 0.83 ALDH1A1 (0.67) ALDH1A1MAPTHPGDLMNAMEN1
SCHEMBL941084 0.81 ALDH1A1 (0.65) ALDH1A1MAPTHPGDLMNAMEN1
SCHEMBL2103067 0.81 ALDH1A1 (0.56) ALDH1A1MAPTHPGDLMNAMEN1
SCHEMBL12463332 0.81 LMNA (0.61) ALDH1A1MAPTHPGDLMNAMEN1
SCHEMBL10373626 0.79 MAPT (0.77) ALDH1A1MAPTHPGDLMNAMEN1
SCHEMBL5496286 0.79 ALDH1A1 (0.61) ALDH1A1MAPTHPGDLMNAMEN1
SCHEMBL1375429 0.74 ALDH1A1 (0.63) ALDH1A1MAPTLMNAMEN1KMT2A
SCHEMBL18031177 0.74 MAPT (0.75) ALDH1A1MAPTHPGDLMNAMEN1
SCHEMBL21592053 0.74 ALDH1A1 (0.55) ALDH1A1MAPTHPGDLMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1819667-B1 SULFONAMIDE COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS VIROBAY INC (US) 2012-10-17 EP disclosed
US-8163735-B2 Sulfonamide compounds as cysteine protease inhibitors VIROBAY, INC. (US) 2012-04-24 US disclosed
US-20090233909-A1 Sulfonamide compounds as cysteine protease inhibitors VIROBAY, INC. (US) 2009-09-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090233909-A1 Sulfonamide compounds as cysteine protease inhibitors CTSF, CTSS, CSTB ALDH1A1 2409/4885MAPT 4402/4885HPGD 2268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.